BIOTECS - Biotechnologie pour la Santé 2010

Monochain HLA class I mice, epitopes identification and preclinical tetramer calibration of interest in human diseases. – HLA

Submission summary

HLA class I monochain transgenic mice expressing the transgenic HLA molecules in a totally H-2 class I negative context and representative of 9 of the most frequent HLA class I alleles (A01.3, A02.01, A24.2, B08.1, B27.5, B35.1, B44.2 et Cw7.1) in all human populations, have been created. They will be used for the identification of epitopes of potential vaccine interest in the Muc1 Tumor Associated Antigen (non small cell lung cancer) and the identification of potential autoimmune epitopes in ? cell autoantigens (GAD, IA-2, IGRP, ZnT8 and preproinsulin) associated with human type 1 diabetis. Tetramers corresponding to these HLA class I molecules and these candidate epitopes will be preclinically validated with these mice.
The human relevance of the candidate epitopes identified with the HLA transgenic mice will be evaluated with peripheral blood lymphocytes of cancer or diabetic patients.


Project coordination

Ronald ROOKE (TRANSGENE)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

INSERM U986 INSERM - DELEGATION DE PARIS V
Transgene TRANSGENE

Help of the ANR 600,000 euros
Beginning and duration of the scientific project: - 48 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter